Drug Testing and Product Training

Transcription

Drug Testing and Product Training
Drug Testing and
Product Training
TABLE OF CONTENTS
A. Drugs of Abuse and
Testing
1. Trends in Drug Use
2. Who’s Using Drug Testing?
3. Types of Testing: Screening and
Confirmation
4. Types of Testing (Table)
5. Screenings Offered by DrugCheck®
6. Detection Times and Cutoff Levels
7. False Positives
B. DrugCheck® Urine Tests
1.
2.
3.
4.
DrugCheck® Urine Tests
Reading a Test Result
Adulterants
K2/Spice
5. Fentanyl
TABLE OF CONTENTS
D. DrugCheck® Saliva
Tests
1.
2.
3.
4.
5.
Oral Fluid Drug Testing
DrugCheck® SalivaScan™
Sponge Saturation Indicator
Features and Benefits
DrugCheck® SalivaScan™ MarketLeading Drug Cutoffs
6. DrugCheck® SalivaScan™ Testing
Procedure
E. DrugCheck® Products
1.
VeriCheck™
F. AlcoCheck™ Products
1.
2.
3.
4.
5.
6.
7.
Urine Alcohol Testing
AlcoCheck™ Saliva Alcohol Screen
Alco-Screen 02
AlcoCheck™ FC90
AlcoCheck™ FC200
AlcoCheck™ Breath Alcohol Screen
AlcoCheck™ Accessories
DRUGS OF ABUSE AND TESTING
DRUGS OF ABUSE AND TESTING
Trends in Drug Use
About 22.6 million Americans or 8.9% of the population are current users
of illicit drugs, meaning they use at least once per month:
• 13.3 million employed Americans
• 4.2 million dependent on illicit drugs
• 15 million dependent on alcohol
Total economic cost = $193 billion
http://www.oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.htm#7.1
http://www.justice.gov/archive/ndic/pubs44/44731/44731p.pdf
DRUGS OF ABUSE AND TESTING
Trends in Drug Use
Treatment admissions for opiates other than heroin rose from 19,870 in
1998 to 111,251 in 2008, over a 450-percent increase
.
80% of the world's supply of opioid analgesics are consumed in
the U.S, but we only have 5% of the world's population
California - Oxy abusers turning to heroin in San Diego County
Naloxone (Narcan) Nasal Spray is a response to opioid
overdose epidemic to avoid needle –sticks and
contracting diseases like Hepatitis and HIV
DRUGS OF ABUSE AND TESTING
Who’s using drug testing?
•
•
•
•
•
•
•
•
•
•
•
•
Workplaces with safety-sensitive
environments
DOT vs. non-DOT
Manufacturing
Construction
Energy (oil, gas, utilities)
Retail
Gaming
Security
Government
Healthcare
Schools
Corrections: Probation/Parole
Corporations
• Wal-Mart
• McDonalds
• GM
• UPS
• Ford
• Sears
• IBM
• GE
• Kroger
• JC Penny/Eck.
1.2 million
364,000
363,000
359,000
346,000
323,000
320,000
313,000
312,000
265,000
DRUGS OF ABUSE AND TESTING
Department of Transportation
Industry
Safety – Sensitive Positions
Commercial Motor
Carriers (FHWA)
Anyone holding a Commercial Driver’s License
Aviation
(FAA)
Flight crew, attendants, instructors, air traffic controllers at facilities
not operated by the FAA or under contract to the U.S. military;
aircraft dispatchers; aircraft maintenance or preventative
maintenance personnel; ground security coordinators and aviation
screeners
Maritime (USCG)
Crewmembers operating a commercial vessel
Mass Transit (FTA)
Vehicle operators, controllers, mechanics and armed security
personnel
Pipeline (RSPA)
Operations, maintenance & emerg. response personnel
Railroad
Hours of Service Act employees: engine, train, & signal services,
dispatchers and operations
DRUGS OF ABUSE AND TESTING
Types of Testing:
Screening and Confirmation
• A screening test is an initial test for drugs.
It can be an onsite test like DrugCheck® or
a test that is done on a chemistry analyzer.
It is usually non-quantitative.
• A confirmation test is often more sensitive
and more specific (selective) that a
screening test and is usually quantitative.
• An example of a confirmation assay is gas
chromatography/masspectrometry (GC/MS
or LC/MS)
• Positive screening tests should be
confirmed by GC/MS or LC/MS.
DRUGS OF ABUSE AND TESTING
Types of Testing
Type
Pros
Cons
Window of Detection
Urine
• Most reliable results
• Least expensive
• Most flexibility in testing
different drugs, alcohol &
nicotine
• Most likely of all methods to
withstand legal challenge
• Specimen can be adulterated,
substituted or diluted
• Limited window of detection
• Typically 1 to 5
days, THC may be
longer
Hair
•
•
•
•
•
• Most expensive
• Test usually limited to basic 5
drugs
• Cannot detect alcohol use
• Will no detect recent drug
use. (1 to 7 days prior to test)
• Depends on length
of hair. Hair growth
= half an inch per
month
• Specimen shows 3
month history
• Less efficient in detecting
THC
• Sample dries out, multiple
sample testing not practical
• More expensive than urine
testing
• Drugs and metabolites do not
remain in oral fluids as long
as in urine
• Approx. 10 to 24
hours
Oral Fluids
Longer window of detection
Greater specimen stability
Can measure chronic use
Easy to ship and store
More difficult to adulterate than
urine
• Sample obtained under direct
observation
• Minimal risk of tampering and
collected in any environment
• Can detect alcohol use
• Reflects recent drug use
DRUGS OF ABUSE AND TESTING
Detection Times and Cutoff Levels
SAMHSA (Substance Abuse and Mental Health Services Administration) Cutoffs
The “Cutoff Level” is the
concentration level established as a
breakpoint or threshold for labeling a
result Positive or Negative (e.g. 50
ng/mL THC or 300 ng/mL Cocaine)
The concentration of a drug is
expressed in nanograms (ng) per
milliliters (mL), or ng/mL. One
nanogram is equal to one billionth of
a gram and 1 mL is equal to about
1/30 of a fluid ounce.
DRUGS OF ABUSE AND TESTING
Screenings Offered by DrugCheck®
Test Strip
Drug
Urine
Saliva
Alcohol
0.04%
Drug
Urine
Saliva
0.02%
Ketamine
1000
50
300, 500
50
Marijuana
25, 50,
300
12,
50(parent)
300
50
MDMA/Ecstasy
500
-
Benzodiazepine
200, 300
10
Methadone
300
30
Buprenorphine
10
5
Methamphetamine
300, 500,
1000
50
Cocaine
150, 300
20
Opiates
300,
2000
40
Cotinine
200
50
Oxycodone
100
40
EDDP/Methadone
100
20
Phencyclidine
25
10
Fentanyl
200
-
Propoxyphene
300
50
10, 50
-
Tramadol
100
-
25
-
Tricyclic
Antidepressants
1000
-
Amphetamine
Barbiturate
GHB
K2/Spice
Test Strip
All cutoffs ng/mL, except alcohol
DRUGS OF ABUSE AND TESTING
Detection Times and Cutoff Levels
Drug Type
Detection Time
Cutoff Levels (ng/mL)
Screen
GC/MS
Up to 24 hours
-
-
2 to 4 days
1000
500
Barbiturates
1 to 2 days
Phenobarb 2 to 3 weeks
300
200
Benzodiazepines
Normal use: 1 to 3 days
Chronic use: weeks
300
200
Buprenorphine
2 to 4 days
10
10
Cocaine
2 to 4 days
300
150
Cotinine
2-4 days
Up to 30 days or longer with
Chronic use
-
-
EDDP/Methadone
1 to 4 days
300
200
Fentanyl
1 to 3 days
-
-
1 day
-
-
Normal use: 1 to 3 days
Chronic use: weeks
-
-
Alcohol
Amphetamine
GHB
K2/Spice
All cutoffs ng/mL, except alcohol
DRUGS OF ABUSE AND TESTING
Detection Times and Cutoff Levels
Drug Type
Detection Time
Cutoff Levels (ng/mL)
Screen
GC/MS
Ketamine
Normal use: Up to 14 days
Chronic use: Up to 30 days
-
-
Marijuana
Up to 10 days (with heavy use
up to 30 days)
50
15
MDMA/Ecstasy
1 to 3 days
500
Parent drug
Methadone
1 to 3 days
300
200
Methamphetamine
2 to 4 days
1000
500
Opiates
2000 or 300 ng/mL
1 to 2 days
2000
2000
Oxycodone
1 to 3 days
100
100
Phencyclidine
Normal use: Up to 14 days
Chronic use: Up to 30 days
-
-
Propoxyphene
3 to 4 days
300
300
Tramadol
1 to 3 days
-
-
Therapeutic dose: 3 days
Chronic use: Up to 4 weeks
-
-
Tricyclic
Antidepressants
All cutoffs ng/mL, except alcohol
DRUGS OF ABUSE AND TESTING
False Positives
POPPY SEED BAGELS Avg. bagel
has 5 grams of poppy seeds yielding
about 600 to 700 ng/mL of morphine
concentration 24 hours after
ingestion. New cutoff level is 2,000
not 300.
PROTON PUMP INHIBITORS, like
protonix, Prilosec, Prevacid, and
Nexium, that treat GERD, may cause
false positives with THC.
SUSTIVA, ATRIPLA (efavirenz) HIV
antiviral causes false positive with
THC. Over $282 million sold in 2003.
New DrugCheck® THC does not
cross-react.
EFFEXOR may cause a false positive
with PCP. Over $2 billion sold in
2003.
ZOLOFT (sertraline) may cause a
false positive for BZD. Over $2.5
billion sold in 2003.
PHENTERMINE (Pro-Fast,
Teramine) may cause a positive
result with Amphetamine.
DAYPRO (Oxaprozin) a popular
medication for arthritis may cause a
false positive for Benzodiazepines.
ADDERALL a treatment for ADHD,
may cause a positive for
amphetamines.
DRUGS OF ABUSE AND TESTING
False Positives
Stribild medication for
HIV-1 (cobicistat /
elvitegravir / emtricitabine /
tenofovir) false positive for
THC and PCP
Naltrexone (Vivtrol) used
in the management of alcohol
dependence and opioid
dependence False positive
for oxycodone.
Naloxone (Narcan) is an
opioid antagonist. Naloxone is
used to counter the effects of
opioid overdose. Also
Naloxone is added to
Suboxone in an effort to
dissuade patients from
injecting the tablets. False
positive for oxycodone
Flexeril (cyclobenzaprine)
muscle relaxant, may cause
false positive with methadone
DRUGS OF ABUSE AND TESTING
False Positives
Tramadol (Ultram) may give a
Zolpidem (Ambien) can give
false positive for burenorphine
especially if the dose is increased.
a false positive for benzodiazepine.
Tramadol works in a similar way as
many antidepressant medications in
that it increases the levels of
serotonin in your brain. Many clients
on suboxone will take tramadol to get
an increase in the euphoric effect.
Egyptians are using the pill as a
recreational drug and also, reportedly,
as an aphrodisiac. But most
commonly, it serves as a cheap
energy boost about $3 for a sheet of
ten pills.
Zolpidem
Benzodiazepine
DRUGS OF ABUSE AND TESTING
Cross Reactivity
Drug Panel
Cross React.
Pharm. Name
Brand Name
Drug Use
Oxycodone
In product insert
Oxycodone
OxyContin/Percolone/
Roxicodone
Moderate to severe pain
In product insert
Hydrocodone
Vicodin
Analgesic with
acetaminophen
In product insert
Hydromorphine
Dilaudid
Pain Management
In product insert
Oxymorphone
Numorphan
Treatment for moderate to
severe pain
In product insert
Codeine
Codeine
Pain Management / cough
medicine
Potential
Dextromethorphan
Dextromethorphan
Treat cough
Potential
Diphenhydramine
Benadryl
Allergies
Potential
Thioridazine
Mellaril
Tranquilizer for psychotic
disorders
Potential
Veniafaxine
Effexor
Antidepressant
In product insert
Phencyclidine
PCP
Phencyclidine
(PCP)
DRUGS OF ABUSE AND TESTING
Cross Reactivity
DrugCheck® Urine Tests
K2/Spice
Synthetic Cannabinoids Timeline
•
•
•
•
•
•
First appearance on the Internet 2004
Europe was original target market
By 2008 widespread in Europe
2008 introduced into US
Widespread in US by late 2008 - 2009
Late 2008 University Hospital Freiburg, Germany first analysis
of incense
• First email Spring 2009
• Laboratory testing available late 2010
• March 1, 2011 classified as Schedule I substance
DrugCheck® Urine Tests
K2/Spice
Street names
Black Mamba, Bombay Blue, Cloud Nine,
Fake Weed, Genie, Spice, Zohai
Looks like
K2 is typically sold in small, silvery plastic bags of dried leaves
and marketed as incense that can be smoked. It is said to
resemble potpourri.
Methods of abuse
K2 products are usually smoked in joints or pipes, but some
users make it into a tea.
Affect on mind
Psychological effects are similar to those of marijuana and
include paranoia, panic attacks, and giddiness.
False Positives – Lamotrigine (Lacmictal)
K2 Symptoms/Side-Effects may include
Increased respiration and elevated blood pressure
(reported up to 200/100-medically dangerous)
Elevated heart rate (reported up to rate of 150medically dangerous)
Increased level of anxiety/agitation leading to
panic attacks (possible suicide attempts)
Synthetic Cannabinoids: CBs
Synthetic Cannabinoids: CBs
K2 Spice Dip Compounds Detected
JWH-018 N-propanoic acid
JWH-018 5-pentanoic acid
metabolite
JWH-018 N-4-hydroxypentyl
JWH-018 N-5-hydroxypentyl
JWH-019 6-hydroxyhexyl
JWH-019 5-hydroxyhexyl
JWH-073 4-butanoic acid
metabolite
JWH-073 N-2-hydroxybutyl
JWH-073 N-4-hydroxybutylame
JWH-122 N-4-hydroxypentyl
JWH-122 N-5-hydroxypentyl
JWH-200 6-hydroxyindole
JWH-210 N-(5-carboxypentyl)
metabolite C26H25NO3
JWH-398 N-pentanoic acid
metabolite
MAM2201 N-pentanoic acid
metabolite
RCS-4 N-(5-carboxypentyl)
metabolite C21H21NO4
DrugCheck® Urine Tests
K2/Spice
JWH-018
(mg/g)
JWH-073
(mg/g)
CP47,497
(n=8) (mg/g)
JWH-250
(mg/g)
K2 Blonde
12
13
-
-
K2 Standard
9
9
-
-
K2 Citron
10
10
-
-
K2* (Unknown)
-
-
6
-
K2 Summit
11
9
-
-
K2 Blue
15
-
-
-
K2 Pink
11
-
-
-
K2 Latte
16
0.28
-
14
K2 Mint
19
0.30
-
-
K2 Silver
8
-
-
16
Spike Gold
20
11
-
-
Spike Maxx
17
-
-
19
Spike Diamond
17
0.07
-
-
Spike Silver
9
16
-
-
Space
10
-
-
-
Herbal blends*
2.0 – 35.9
-
1.1 – 16.9
-
Chemicals - Prevalance 2010
July – December 2010
Chemicals – Prevalence 2012
Jan–Mar 2012
Fentanyl
Killer Heroin’ Causing Fatal Overdoses in East
As the number of people who use, and fatally overdose on,
heroin has skyrocketed in recent years, authorities are seeing
the return of an alarming development: heroin that, often
unbeknownst to the user, is spiked with fentanyl.
Md. Has 37 Deaths From Heroin,
Fentanyl Overdoses
BALTIMORE — Maryland’s medical examiner says there have
been at least 37 deaths since September in the state from a
batch of heroin that is tainted with fentanyl.
Fentanyl
Fentanyl is a powerful synthetic opiate analgesic .
It is typically used to treat patients with severe pain, or to manage
pain after surgery.
It is also sometimes used to treat people with chronic pain who
are physically tolerant to opiates.
It is a schedule II prescription drug
Names
In its prescription form, fentanyl is known as Actiq, Duragesic, and
Sublimaze. Street names for the drug include Apache, China girl,
China white, dance fever, friend, goodfella, jackpot, murder 8, TNT,
as well as Tango and Cash.
Fentanyl is 100 times more potent than morphine.
100 micrograms of Fentanyl approximately equivalent to 10 mg
of morphine. 1mg = 1000 micrograms (ug)
Some heroin dealers mix fentanyl powder with heroin in order
to increase potency or compensate for low-quality heroin.
The mixture of fentanyl and heroin is known as "magic" or "the
bomb", among other names, on the street
Krokodil
DrugCheck® Urine Tests
DrugCheck® Urine Tests
Test Principle
DrugCheck® Urine Tests
Reading a Test Result
• Presumptive Positive: One colored line in control
(C) zone; no colored line in test (T) zone
• Negative: Colored lines are visible in both control
(C) and test (T) zones, indicates concentration of
drug is below detection limit of test or not present
• Note: Test lines (T) may have varying intensity,
either weaker or stronger in color than that of the
control line (C). However, any indication of a line
in the test region should be interpreted as a
negative result.
DrugCheck® Urine Tests
Adulterants
DrugCheck® Urine Tests
Adulterants
The Wedge (La Cuña)
DrugCheck® Urine Tests
Adulterants
Adulterant
Drug Test Affected
Adulteration Strip Affected
THC, OPI, AMP
pH, SG, Oxid
OPI, AMP
pH, SG
AMP
SG
THC, COC, OPI, PCP, AMP
SG, Oxid
Stealth
THC, COC, PCP
Oxid
Instant Clean
THC, COC, PCP
Oxid
THC, COC, OPI, PCP
SG
Chlorine Bleach
Liquid Drain Cleaner
Vinegar
Pyridinium Cl Cr (PCC)
UR’n Kleen
DrugCheck® Urine Tests
DrugCheck® NxScan
Procedure: Specimen Collection
9.
Check temperature (normal range
from 90° to 100°F or 32°to 38°C)
and observe specimen for foreign
material and/or discoloration
If the temperature is not within the
normal range, the specimen is
considered invalid and must be
retested.
Peel the privacy label.
Read results at 5 minutes.
10. Pull privacy label and read drug test
strip results at 5 minutes. Read
adulterant strips at 1 minute and
alcohol strips at 2 minutes.
11. Secure container by tightening lid as
far as it will turn, apply security seal,
and have donor and test
administrator both sign and date
seal, as well as initial and date the
NxScan label.
DrugCheck® Urine Tests
Adulterants
•
•
•
Adulteration results are obtained by comparison of the colored pads on reacted
strips to color blocks on the Adulterant Color Chart.
Adulterated urine will show result colors similar to those in the “Abnormal”
columns of the color chart, either high or low. Unadulterated samples will show
strip colors similar to those in the “Normal” column.
Adulterants available:
–
–
–
–
–
–
•
Creatinine (CR)
Glutaraldehyde (GL)
Nitrite (NI)
Oxidants/Bleach (OX)
pH
Specific Gravity (SG)
EDI offers 3 adulterants per strip
–
CR-GL-NI
–
OX-pH-SG
DrugCheck® Urine Tests
DrugCheck® NxStep
• Configurations of up to 15 drugs and/or
adulterants and alcohol
• FDA cleared for 17 drugs
• Combined collection cup and testing
device delivers instant results,
convenience, accuracy
• Detects presence of drug metabolites
in minutes, using SAMHSA cutoffs
DrugCheck® Urine Tests
DrugCheck® NxScan
Procedure: Specimen Collection
1. Have available for use a Chain of
Custody form (COC) or Test
Results Record template.
for and remove cleaners and other
substances, secure toilet tank top or
blue tank water.
2. Require the donor to present a
photo identification.\
6. Visually inspect foil package
containing the cup to ensure that
the package has not been
compromised. Tear open the foil
pouch and remove the test cup.
3. Ask donor to remove any
unnecessary outer clothing and
empty all pockets.
NOTE: Urine Specimens can be
transferred from a urine collection
container into the DrugCheck® Test
Cup, if necessary
4. Keep all backpacks and purses out
on the restroom. Insure that all
backpacks, wallets and purses are
secured, preferably in a locked
cabinet. If using a lockable cabinet
of container, make sure that the
donor is given the key.
5. Secure the collection site
(restroom).
Turn off water sources (sink faucets),
ensure blue toilet water, inspect site
7. Issue the device to the individual to
be tested. Instruct the donor not to
flush the toilet or turn the water on
and to open the door when they
are done.
8. Have the individual urinate directly
into the DrugCheck® Test Cup.
Ensure that the specimen is above
the minimum level (30 mL) line on
the test label.
DrugCheck® Urine Tests
DrugCheck® NxScan
Procedure: Specimen Collection
9.
Check temperature (normal range
from 90° to 100°F or 32°to 38°C)
and observe specimen for foreign
material and/or discoloration
If the temperature is not within the
normal range, the specimen is
considered invalid and must be
retested.
Peel the privacy label.
Read results at 5 minutes.
10. Pull privacy label and read drug test
strip results at 5 minutes. Read
adulterant strips at 1 minute and
alcohol strips at 2 minutes.
11. Secure container by tightening lid as
far as it will turn, apply security seal,
and have donor and test
administrator both sign and date
seal, as well as initial and date the
NxScan label.
DrugCheck® Urine Tests
DrugCheck® NxScan
• Flat panel cup for
copying or scanning for
permanent record
• Configurations of up to
14 drugs and/or
adulterants and alcohol
• FDA cleared for 17
drugs
DrugCheck® Products
VeriCheck
•
•
•
•
•
•
Automated interpretation
One-click activation
Qualitative analysis of assays
Results database – produce and print reports
Read/interpret multiple tests with minimal user interaction
Bar-coded template contains all information required to
process device
• Read lateral-flow tests with:
– 1 to 14 strips
– Color pads, such as adulterants:
pH, NI, GL, CR, OX, SG
• Affordable, accurate diagnostic test reading system for
hospitals, point-of-care organizations, labs and more
DrugCheck® Urine Tests
Drugcheck Advantages
What distinguishes DrugCheck NxStep and NxScan test
cups from other on-site products is:
– No handling or manipulation to activate testing
– No tipping or tilting cup to activate test
– No dipping reagent strips or test cards into specimen
– No dripping specimen with pipettes
– Compatible with VeriCheck Results Manager
– U.S. made
DrugCheck® Urine Tests
DrugCheck® Dip Tests
• Single- and multi-drug devices, as well as single test
strips
• Rapid, qualitative immunoassay - detect up to 14
drugs; FDA cleared for 17 drugs
• Dip test strips in urine sample for 15 seconds; read
results at 5 min
• Flood-proof label
• 18-month shelf life
• No urine to pipette
DrugCheck® Urine Tests
DrugCheck® 9-Panel Pipette
• Rapid, qualitative immunoassay for detection of up to
nine drugs of abuse at SAMHSA cutoff levels
– AMP/COC/OPI/THC/MET/BZO/BAR/PCP/MTD
• Simply transfer urine via pipette (dropper) to wells of test
device; read test results at 5 min
• 18-month shelf life
• No instrumentation
• Made in U.S.A.
DrugCheck® Saliva Tests
DrugCheck® Saliva Tests
SalivaScan™ Testing Procedure
1
Remove device
from foil pouch
Remove collection swab
from plastic pouch
DrugCheck® Saliva Tests
Procedure: Specimen Collection
2
IMPORTANT: DONORS SHOULD NOT PLACE ANYTHING
(INCLUDING FOOD, DRINK, GUM, OR TOBACCO
PRODUCTS) IN THEIR MOUTH FOR AT LEAST 10 MINUTES
PRIOR TO THE PROCEDURE. DO NOT BITE, SUCH, OR
CHEW ON THE SPONGE. REFRAIN FROM TALKING WHILE
COLLECTION SWAB IS IN THE MOUTH.
DrugCheck® Saliva Tests
Procedure: Specimen Collection
2
Sponge
Saturation
Indicator
Donor may remove
swab from mouth when
color appears in the
indicator window
The purpose of Step 2 is to saturate the sponge with saliva. With collection
swab, have donor sweep the inside of mouth (cheek, gums, tongue) several
times, then hold swab in closed mouth until color on the saturation indicator
strip appears in the indicator window of the collection swab. Donor must leave
swab in mouth until instructed to remove it. Note: If at 7 minutes, color on
saturation indicator has not appeared in indicator window, proceed with
test.
DrugCheck® Saliva Tests
Procedure: Assay
3
Remove collection swab (B) from mouth and
insert the sponge first into the screening device
(A), pushing until the locking flange locks in
place in the bottom of the device.
NOTE: Once the collection swab locks in place,
the device is airtight, tamper evident, and ready
to dispose of or send to lab for confirmation (on
presumptive positive result).
DrugCheck® Saliva Tests
Procedure: Assay
3
Ensure that specimen is contacting all test
strips. If not, rotate the device side to side / front
to back to disperse the specimen within the
chamber. With specimen dispersed, set device
upright on flat surface and keep upright while
test is running.
DrugCheck® Saliva Tests
Procedure: Read Results
4
Read negative results as soon as two lines
appear on any test strip, often within 2 minutes.
Any indication of a line in the test region (T)
should be considered a line, and therefore a
negative result. Read presumptive positive
results within 10 minutes. If the device includes
alcohol, read the alcohol strip at 2 minutes.
DrugCheck® Saliva Tests
DrugCheck® SalivaScan™
• “SalivaScan is our single greatest
accomplishment as a company thus
far. This device is unequaled in the
industry and will help define EDI as
not just a manufacturer, but an
innovator. With this device our
Sales and Marketing team has the
opportunity to take this company to
a whole new level!” – Paul Johnson
DrugCheck® Products
VeriCheck
•
•
•
•
•
•
Automated interpretation
One-click activation
Qualitative analysis of assays
Results database – produce and print reports
Read/interpret multiple tests with minimal user interaction
Bar-coded template contains all information required to
process device
• Read lateral-flow tests with:
– 1 to 14 strips
– Color pads, such as adulterants:
pH, NI, GL, CR, OX, SG
• Affordable, accurate diagnostic test reading system for
hospitals, point-of-care organizations, labs and more
AlcoCheck™ Products
Urine Alcohol Testing
Alcohol is responsible in the world for
2.5 million deaths and results in
disability in approximately 58.3 million
people per year.
AlcoCheck™ Products
Urine Alcohol Testing
Factors that Affect Alcohol Absorption
• Time of consumption
• Type of alcoholic
beverage
• Presence of food in
stomach
• Body weight
• Rate of alcohol
absorption
AlcoCheck™ Products
Urine Alcohol Testing
Alcohol and the Law
Try the drink wheel:
http://www.intox.com/wheel/drinkwheel.asp
AlcoCheck™ Products
Urine Alcohol Testing
Alcohol and the Law
• 1939-1964:
intoxicated = 0.15%
BAC
• 1965: intoxicated =
0.10% BAC
• 2003: intoxicated =
0.08% BAC
At least we don’t live in
France, Germany, Ireland, or
Japan (0.05%) or especially
Sweden (0.02%)!
AlcoCheck™ Products
Urine Alcohol Testing
• Peak urine alcohol
levels are reached
45 to 60 minutes
after alcohol
ingestion
• Alcohol may be
detected in the
urine for 1 to 2
hours longer than it
is detected in the
blood
AlcoCheck™ Products
Urine Alcohol Testing
• Negative result shows no change from the original light yellow
color on the test strip pad
• Urine with alcohol at specific levels will be indicated on the
test strip pad according to the color on color chart
Part No. 40901 and 40901C
AlcoCheck™ Products
AlcoCheck Saliva Alcohol Screen
• Rapid, semi-quantitative detection of alcohol in saliva
• Place test strip in mouth for 10 sec; after 2 min compare
reactive pad to color to color chart on pouch
• Easy-to-read interpretation chart provided on package
• Adulteration and dilution is not an issue
• Indicates recent alcohol usage
• Gender neutral
Part No. 40900
AlcoCheck™ Products
AlcoCheck Breath Alcohol Screen
• Simple, convenient method to detect alcohol use
and to estimate levels of intoxication
• Pass/fail design detects alcohol at
different threshold levels
- .02, .04, .05, .08
• Procedure: Squeeze tube to crush
the ampoule, then blow into end of tube for 12 sec
• Yellow crystals remain unchanged if alcohol is not present at
the test’s threshold. Alcohol in the breath that meets or
exceeds the test’s threshold turns yellow crystals
to a pale blue/green color within 2 min
# 40902, # 40904, # 40905, # 40908 - Boxes of 25
AlcoCheck™ Products
AlcoCheck FC90
•
•
•
•
•
•
•
•
•
•
Electrochemical European fuel cell sensor
Display range: 0.000-0.200%BAC
Audible sound alarm if above 0.05%BAC
Low-battery indicator/Auto power-off
Calibration interval: 12 months
Blowing time: 6 sec
Memory: 5 records
Blowing flow detection
1-year warranty
CE registered, DOT cleared
AlcoCheck™ Products
AlcoCheck FC200
• Results can be printed via USB cable
connection to optional printer
• Onboard memory
• Advanced European fuel cell sensor
• Low-battery indicator/Auto power-off
• Advanced blow-flow detection
• Available in EU format
• 1 year warranty
• Accuracy established at BAC
of 0.008; backlit screen changes
color when alcohol content
of sample exceeds 0.08